This protocol represents the first in human study of SRX246, and is being conducted to begin to establish a safety profile, and collect human tolerability and pharmacokinetic data of orally administered SRX246.
This is the first study of SRX246 in humans, and is being conducted to begin to establish a safety profile of orally administered SRX246.